Heron Therapeutics, Inc. ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Mark Hensley as Chief Operating Officer. Mr. Hensley has more than ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Finding a better way to treat cancer, tackling the nursing shortage or just providing a better way to order tests are ...